EMJ recently spoke to Derek Gilroy, Head of Department of Experimental & Translational Medicine, University College London, UK, about his career in research, and the paradigm shift in how inflammation is being understood.
Gilroy reflects on his pioneering work in the study of chronic inflammatory diseases, including his arguments regarding the nature of the body’s natural resolution pathways and the resolution of inflammation as an ongoing biological process. He also discusses the nature of neuroimmune interactions, intermediate monocytes, and the biggest challenges in translating pro-resolution biology into treatments.
Stay at the forefront of allergy and immunology and keep up with the latest advancements, key clinical trial results, and in-depth coverage of the field by subscribing.
Read Gilroy’s full interview with EMJ here.
